Forecast

The analysts' average price target is +2,52€ (+366,67%). The median is +2,51€ (+364,81%).

Buy	1
Hold	2
Sell	0

News Go to news feed

TerrAscend reports Q1 growth and higher margins

TerrAscend returned to revenue growth in Q1 2026 with net revenue of $65.5 million and an improved gross margin of 52.8%. Adjusted EBITDA was $17.4 million (26.5% margin), net loss was $6.8 million, and cash rose to $39.1 million. Retail revenue grew sequentially while wholesale revenue declined; the company reported 15 consecutive quarters of positive cash flow. For Q2, TerrAscend expects year-over-year growth of 2–3% and plans a record number of new product SKUs; expected EPS for upcoming quarters is -$0.03. » More on de.investing.com
TerrAscend shareholders approve director elections and option amendments

At the annual meeting, TerrAscend shareholders approved the election of all proposed directors, the reappointment of the auditor, and changes to stock options for insiders. The adjustment of option prices is tied to a minimum service period, which outgoing CFO Keith Stauffer is not expected to fulfill. Despite significant share price losses over the past six months, the company is projected to achieve improved profitability. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2019, Terrascend has already paid 0,55€ in dividends. The last payout was in November 2019.

Financials

In the last quarter, Terrascend had revenue of 58.81m€ and net profit of −7.06m€

(EUR)	Jun 2026	YoY
Revenue	+58.81m	6,63%
Gross profit	+31.76m	12,64%
Net profit	−7.06m	83,16%
EBITDA	+4.22m	64,44%

Fundamentals

Metric	Value
Market capitalization	+516.68m€
Number of shares	349.95m
52-week high/low	+2,65€ - +0,86€
Dividends	No
Beta	2
P/E ratio	−4,72
PEG ratio	−0,04
P/B ratio	+2,38
P/S ratio	+0,72

Company profile

TerrAscend Corp. kultiviert, verarbeitet und verkauft medizinisches Cannabis und Cannabis für Erwachsene in Kanada und den Vereinigten Staaten. Es produziert und vertreibt aus Hanf gewonnene Wellness-Produkte im Einzelhandel und stellt handwerklich hergestellte Cannabis-Esswaren her. Das Unternehmen betreibt außerdem drei Einzelhandelsabgabestellen unter dem Markennamen Apothecarium in Kalifornien und Pennsylvania. Darüber hinaus besitzt es verschiedene synergetische Produkte unter den Marken Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections und Arise Bioscience Inc. Mit Stand vom 6. April 2022 betrieb das Unternehmen 26 Abgabestellen, darunter 3 Cookies-Abgabestellen in Michigan und 1 in Toronto. TerrAscend Corp. wurde im Jahr 2017 gegründet und hat seinen Sitz in Mississauga, Kanada.

Name	Terrascend
CEO	Ziad Ghanem
Headquarters	Mississauga, on Canada
Website	terrascend.com
Sector	Consumer Staples
Industry	Food Products
IPO	11/17/2017
Employees	972